Literature DB >> 8376606

Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.

M Murata1, M Fukuyama, K Satoh, Y Fujimura, A Yoshioka, H Takahashi, M Handa, Y Kawai, K Watanabe, Y Ikeda.   

Abstract

Platelets exposed to shear stress aggregate in the absence of exogenously added agonists, utilizing distinct platelet membrane receptors and ligands depending upon the level of shear stress applied. Using a modified cone and plate type viscometer, we previously demonstrated that, under low shear stress (18 dyn/cm2), aggregation is mediated by platelet membrane glycoprotein (GP) IIb-IIIa and fibrinogen, whereas aggregation induced by high shear stress (108 dyn/cm2) requires the binding of von Willebrand factor (vWF) to both GPIb-IX and GPIIb-IIIa (Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, I. Itagaki, et al. 1991. J. Clin. Invest. 87:1234-1240). Here we report that vWF-dependent aggregation occurs under low shear stress in citrated platelet-rich plasma (PRP) from two types of congenital bleeding disorders, platelet-type von Willebrand disease (vWD) and type IIB vWD, in both of which ristocetin-induced aggregation is known to be heightened. Aggregation induced by low shear stress was enhanced in both types of disorders compared to normal controls, and the enhancement was completely abolished by anti-vWF monoclonal antibody NMC-4, which blocks the GPIb-binding site on vWF. Under high shear stress, the extent of maximal aggregation was not different between controls and the patient groups although maximal aggregation was reached much more quickly in the latter. When citrated PRP was exposed to a gradient of shear stress (6 to 108 dyn/cm2 over a 5-min period), vWF-dependent aggregation, as judged from the inhibitory effect of NMC-4, first occurred at 14 dyn/cm2 in platelet-type vWD and at 10-12 dyn/cm2 in type IIB vWD, as compared with more than 81 +/- 20.1 dyn/cm2 in control platelets. These results suggest that an abnormality in either vWF or GPIb-IX triggers the aggregation-inducing interaction of the two molecules under low shear stress, which might explain the intravascular platelet clumping, that presumably underlies the thrombocytopenia observed in these bleeding disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376606      PMCID: PMC288303          DOI: 10.1172/JCI116735

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.

Authors:  J L Miller; D Cunningham; V A Lyle; C N Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.

Authors:  K A Cooney; W C Nichols; M E Bruck; W F Bahou; A D Shapiro; E J Bowie; H R Gralnick; D Ginsburg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

Authors:  Y Ikeda; M Handa; K Kawano; T Kamata; M Murata; Y Araki; H Anbo; Y Kawai; K Watanabe; I Itagaki
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.

Authors:  J Ware; J A Dent; H Azuma; M Sugimoto; P A Kyrle; A Yoshioka; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.

Authors:  A M Randi; I Rabinowitz; D J Mancuso; P M Mannucci; J E Sadler
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; P J Bridge; I R Peake; D P Lillicrap
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

7.  von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.

Authors:  M H Kroll; T S Harris; J L Moake; R I Handin; A I Schafer
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 8.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

9.  Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease.

Authors:  A S Ribba; J M Lavergne; B R Bahnak; A Derlon; G Piétu; D Meyer
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113

10.  The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.

Authors:  Y Fujimura; L Z Holland; Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

View more
  6 in total

1.  Mimotope/anti-mimotope probing of structural relationships in platelet glycoprotein Ib alpha.

Authors:  J L Miller; V A Lyle
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.

Authors:  Kannayakanahalli M Dayananda; Indrajeet Singh; Nandini Mondal; Sriram Neelamegham
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

3.  Non-dimensional analysis of retinal microaneurysms: critical threshold for treatment.

Authors:  Elishai Ezra; Eliezer Keinan; Yossi Mandel; Michael E Boulton; Yaakov Nahmias
Journal:  Integr Biol (Camb)       Date:  2013-03       Impact factor: 2.192

4.  Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging.

Authors:  Nipa A Mody; Michael R King
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

5.  A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD.

Authors:  Qizhen Shi; Scot A Fahs; Jeremy G Mattson; Hongyin Yu; Crystal L Perry; Patricia A Morateck; Jocelyn A Schroeder; Jessica Rapten; Hartmut Weiler; Robert R Montgomery
Journal:  Blood Adv       Date:  2022-05-10

6.  Shear Stress Alterations Activate BMP4/pSMAD5 Signaling and Induce Endothelial Mesenchymal Transition in Varicose Veins.

Authors:  Karthika Chandran Latha; Ahalya Sreekumar; Vyshna Beena; Binil Raj S S; RaviKumar B Lakkappa; Ravi Kalyani; Radhakrishnan Nair; Saligrama Ramegowda Kalpana; Chandrasekharan C Kartha; Sumi Surendran
Journal:  Cells       Date:  2021-12-17       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.